For the quarter ending 2025-06-30.
| Income Statement | 2025-06-30 | |||
|---|---|---|---|---|
| Research and development | 17,410 | |||
| General and administrative | 10,081 | |||
| Total operating expenses | 27,491 | |||
| Loss from operations | -27,491 | |||
| Other income (expense), net | -8 | |||
| Interest income, net | 836 | |||
| Total other income, net | 828 | |||
| Net loss | -26,663 | |||
| Basic EPS | -0.56 | |||
| Diluted EPS | -0.56 | |||
| Basic Average Shares | 47,619,724 | |||
| Diluted Average Shares | 47,619,724 | |||
Vigil Neuroscience, Inc. (VIGL)
Vigil Neuroscience, Inc. (VIGL)